Desktop Site
|
28 Mar 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
500420
Company
TORRENT PHARMACEUTICALS LTD.
Exchange Received Time
28/09/2022 20:20:25
Exchange Disseminated Time
28/09/2022 20:20:25
Time Taken
00:00:00
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 |
9/28/2022 8:20:25 PM
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that: The USFDA inspected our manufacturing facility at Indrad, Gujarat from 19-Sep-22 to 28-Sep-22. At the end of the inspection, we have been issued a 'Form 483' with 3 observations. None of these observations were related to data integrity. We will respond to the USFDA within stipulated timeline and work closely with USFDA to address the observations at the earliest. We will keep the stock exchanges informed of any material development relating to the above in the future. Please take the information on record.
Attachment
<< Back
Recently Viewed